Cargando…

Neuropathology associated with SARS-CoV-2 infection – Authors' reply

Detalles Bibliográficos
Autores principales:	von Weyhern, Claus Hann, Kaufmann, Ines, Neff, Frauke, Kremer, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825920/ https://www.ncbi.nlm.nih.gov/pubmed/33485447 http://dx.doi.org/10.1016/S0140-6736(21)00097-0

Ejemplares similares

Early evidence of pronounced brain involvement in fatal COVID-19 outcomes
por: von Weyhern, Claus Hann, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

SARS-CoV-2 infection in conjunctival tissue – Authors' reply
por: Hui, Kenrie PY, et al.
Publicado: (2020)

Neuropathology associated with SARS-CoV-2 infection
por: Glatzel, Markus, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Egervari, Kristof, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Nasrallah, MacLean P, et al.
Publicado: (2021)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Stability of SARS-CoV-2 in different environmental conditions – Authors' reply
por: Chin, Alex W H, et al.
Publicado: (2020)

Transmission of SARS-CoV-2: still up in the air – Authors' reply
por: Greenhalgh, Trisha, et al.
Publicado: (2022)

Practical measures for SARS-CoV-2 infection prevention – Authors' reply
por: Llibre, Josep M, et al.
Publicado: (2022)

SARS-CoV-2 rapid antigen detection tests – Authors' reply
por: Peeling, Rosanna W, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
por: Lohse, Stefan, et al.
Publicado: (2020)

Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)

Neutrophils as a pallbearer for SARS-CoV-2 disease burden – Authors’ reply
por: Lutter, René, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Unclear conclusions on SARS-CoV-2 elimination versus mitigation – Authors' reply
por: Oliu-Barton, Miquel, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals – Authors' reply
por: Lalvani, Ajit, et al.
Publicado: (2022)

Association of SARS-CoV-2 renal tropism with acute kidney injury – Authors' reply
por: Braun, Fabian, et al.
Publicado: (2020)

The ability of the neonatal immune response to handle SARS-CoV-2 infection – Authors' reply
por: Gale, Chris, et al.
Publicado: (2021)

Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? – Authors' reply
por: Tsang, Nicole Ngai Yung, et al.
Publicado: (2021)

Misclassification bias in estimating clinical severity of SARS-CoV-2 variants – Authors' reply
por: Nyberg, Tommy, et al.
Publicado: (2022)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK – Authors' reply
por: Black, James R M, et al.
Publicado: (2020)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 – Authors' reply
por: Keusch, Gerald T, et al.
Publicado: (2021)

Fulminant Encephalitis Caused by SARS-CoV-2 in a Two-Month-Old Infant: Authors’ Reply
por: Marwa, Abdelbari, et al.
Publicado: (2023)

The Authors' Reply: Need for a multi-pronged population-level strategy to manage SARS-CoV-2 infection
por: Subramanian, S. V., et al.
Publicado: (2021)

Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Authors’ Reply
por: Dhochak, Nitin, et al.
Publicado: (2022)

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases – Authors' reply
por: Spinelli, Matthew A, et al.
Publicado: (2021)

The importance of external quality assessment data in evaluating SARS-CoV-2 virus genome detection assays – Authors‘ reply
por: Au, Wing Ying, et al.
Publicado: (2022)

Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”
por: Marcus-Mandelblit, Nufar, et al.
Publicado: (2023)

Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies – Authors' reply
por: Moor, Matthias B, et al.
Publicado: (2022)

Reply to “SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection”
por: Sattar, Yasar, et al.
Publicado: (2020)

Reply to: The role of pets in SARS-CoV-2 transmission: an exploratory analysis
por: Galmiche, Simon, et al.
Publicado: (2022)

SARS-CoV-2 variant-related abnormalities detected by prenatal MRI: direct or indirect effects of the infection must be demonstrated—Authors’ reply
por: Kienast, Patric, et al.
Publicado: (2023)

Author's overview: identifying SARS-CoV-2 antiviral compounds
por: Diffley, John F.X.
Publicado: (2021)

In Reply to ‘Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?’
por: De Vriese, An S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q5l9ohjsj1v546t37q0icce2qh